# Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve Disease

> **NCT01013688** · PHASE3 · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 150 (estimated)

## Conditions studied

- Rheumatic Valve Disease
- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Cardioblate® Surgical Ablation System

## Key facts

- **NCT ID:** NCT01013688
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2009-05
- **Final completion:** 2010-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2009-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013688, "Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01013688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*